Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Freeline Therapeutics Holdings Plc Adss (FRLN)

Freeline Therapeutics Holdings Plc Adss (FRLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) Could Find Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN), indicating that the stock has found support. This, combined with an upward...

FRLN : 0.5990 (-3.39%)
The Zacks Analyst Blog Highlights Absci Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics

Absci, Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics are part of Zacks top Analyst Blog.

AXLA : 0.9009 (-1.12%)
PLRX : 16.97 (-4.82%)
FRLN : 0.5990 (-3.39%)
ABSI : 2.40 (-9.43%)
DICE : 34.51 (-5.40%)
5 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Let us look at some drug/biotech stocks, ABSI, AXLA, FRLN, DICE and PLRX, which are poised to beat on second-quarter earnings.

AXLA : 0.9009 (-1.12%)
PLRX : 16.97 (-4.82%)
FRLN : 0.5990 (-3.39%)
ABSI : 2.40 (-9.43%)
DICE : 34.51 (-5.40%)
Freeline Announces July 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on July 29, 2022, the Company granted...

FRLN : 0.5990 (-3.39%)
Here's Why Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) Could be Great Choice for a Bottom Fisher

Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart...

FRLN : 0.5990 (-3.39%)
Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) Upgraded to Buy: Here's What You Should Know

Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher...

FRLN : 0.5990 (-3.39%)
Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress

FLT180a generated protective FIX levels with no bleeding or need for FIX replacement The treatment was well tolerated with a good safety profile LONDON,...

FRLN : 0.5990 (-3.39%)
Freeline Announces June 2022 Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

LONDON, July 01, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on June 30, 2022, the Company granted a...

FRLN : 0.5990 (-3.39%)
Freeline to Present New Clinical Data for FLT180a in Hemophilia B at International Society on Thrombosis and Haemostasis Congress

LONDON, June 24, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced the upcoming presentation of new and...

FRLN : 0.5990 (-3.39%)
10 Penny Stocks with > 1,000% Upside

Rising interest rates, sky-high inflation, and geopolitical concerns have dragged down the S&P 500 (SPX) and NASDAQ Composite (NDX) into bear market territory. While all this sounds rather doom and gloom,...

AMTI : 1.1300 (-4.24%)
ANGN : 0.8401 (-8.68%)
CKPT : 0.5249 (-9.50%)
EFTR : 0.4301 (-1.83%)
FRLN : 0.5990 (-3.39%)
GLYC : 2.25 (-1.75%)
MGNX : 6.38 (-7.54%)
OCUP : 3.22 (-1.23%)
PHAS : 0.0701 (-26.21%)

Barchart Exclusives

EPA Proposals Would Bring Major Changes to the U.S. Biofuel Efforts
Last Week’s Moves Corn 640-0 (-4.92%) | Soybeans 1438-6 (-1.41%) | SRW Wheat 737-2 (-5.06%) KC Wheat 846-6 (-5.28%) | Live Cattle 156.150 (+0.97%) | Lean Hogs 90.875 (+7.11%) _________________________________________________________________________________________ Welcome to your weekly agriculture report, where we cover everything you’ll need to know for the week ahead. This week,... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar